Antengene Biologics Limited clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.
- Notable: CLINCH-3 · ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Recruitment opened
- Notable: ATTRACT · ATG-201 · Autoimmune Diseases Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 2 | |
| Phase 1/2 | 1 | |
| Phase 3 | 1 |
Disease areas by active trials
Lupus (SLE) (1) · Scleroderma (1)
Get alerts when Antengene Biologics Limited's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.